Ms. Laura Marie Mertz, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 261 Old Forge Xing, Devon, PA 19333 Phone: 484-362-8110 |
Cara Marie Filippelli, M.S SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 305 Dundee Pl, Devon, PA 19333 Phone: 484-459-9971 |
Rebecca Greenhow, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 Lancaster Ave, Devon, PA 19333 Phone: 484-919-5601 |
Jessica Bull, ST Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 445 N Valley Forge Rd Ste 118, Devon, PA 19333 Phone: 877-407-3422 |
Kari A Hoffer, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 445 N Valley Forge Rd, Suite 118, Devon, PA 19333 Phone: 877-407-3422 Fax: 877-407-4329 |
Sarah E Schmidt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 890 Lancaster Ave, Devon, PA 19333 Phone: 610-225-2451 |
Mrs. Ashley Shapero, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 890 Lancaster Ave, Devon, PA 19333 Phone: 610-225-2451 Fax: 610-964-6166 |
Kelly Jo Beltz, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 445 N Valley Forge Rd, Suite 118, Devon, PA 19333 Phone: 877-407-3422 Fax: 877-407-4329 |
Mrs. Maureen Michele Colket, M.A. CCC/SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 235 W Lancaster Ave, Devon, PA 19333 Phone: 610-688-8080 |
Ms. Anastasia Antoniadis, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 62 Old Forge Xing, Devon, PA 19333 Phone: 610-202-9060 |
News Archive
There is growing awareness that air pollutants are playing a critical role in the development of neurodegenerative diseases.
Nova Southeastern University's medical school, the College of Osteopathic Medicine, recently received a $2.3 million federal grant to develop an academic curriculum to train medical and other students in the health professions to better meet the needs of patients in a changing national health care system.
Western Oncolytics Ltd., a biotech company specializing in immuno-oncolytic cancer therapies, has closed $275,000 in seed funding. The proceeds are planned to set a path toward clinical trials and execute initial manufacturing for its novel virus-based cancer therapy, which delivers genes to guide the immune system to kill cancer cells.
In their upcoming G&D paper, Dr. Robert Tjian (UC Berkeley) and colleagues reveal how histone gene expression is differentially regulated during Drosophila development.
› Verified 8 days ago